Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spectranetics has completed the closing of the transaction to acquire the endovascular business of Kensey Nash and has begun commercialization of the acquired products.
Subscribe to our email newsletter
The products acquired consist of the QuickCat thrombus aspiration catheter, ThromCat thrombectomy device and SafeCross products used to treat chronic total occlusions.
John Schulte, Spectranetics’s president and CEO, said: “The closing was completed ahead of schedule and integration activities have already been initiated.
“Training of many of our vascular intervention sales professionals has been completed and we look forward to marketing the acquired products and maximizing their potential with the manufacturing and product development support of Kensey Nash.”